Clinical Trial Update: Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a combination therapy of Ectiecinib, Pemetrexed, and Platinum in metastatic non-squamous non-small cell lung cancer with EGF…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ectiecinib (Ectiecinib)
• Pemetrexed (pemetrexed)
• Platinum (Platinum-based chemotherapy)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Non-squamous Non-small Cell Lung Cancer | Phase 3 | Status: UNKNOWN